 |
L-IHC: Layered ImmunioHistochemistry20/20 has developed a patented platform that can be used to simultaneously identify numerous tumor biomarkers and predict optimal patient response to available targeted cancer therapies. |
 |
|
 |
PROTEIN MICROARRAYS20/20 has developed a protein microarray platform featuring a library of proprietary biomarkers. This platform will be used in a number of tests to be launched for the early detection of several forms of cancer including lung, head & neck cancers. Currently, there are no tests commercially available for early detection of these cancers. This test will allow detection of cancers when early treatment can yield the highest rates of success and survival. |
|